Agile Therapeutics
AGRX
AGRX was delisted on the 25th of March, 2024.
37 hedge funds and large institutions have $154M invested in Agile Therapeutics in 2015 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 0 closing their positions.
233% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 3
95% more funds holding
Funds holding: 19 → 37 (+18)
92% more capital invested
Capital invested by funds: $80.1M → $154M (+$73.5M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$12.8M |
| 2 |
AC
Aisling Capital
New York
|
+$7.12M |
| 3 |
PAI
ProQuest Associates IV
Naples,
Florida
|
+$7.12M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.72M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
-$4.78M |
| 2 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
-$648K |
| 3 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$35.1K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFA
26
BlackRock Fund Advisors
San Francisco,
California
| $236K | +$17.5K | +1 | +8% |
|
|
SIM
27
Spark Investment Management
New York
| $231K | +$228K | +13 | New |
|
28
Millennium Management
New York
| $193K | +$175K | +10 | New |
|
29
Northern Trust
Chicago,
Illinois
| $136K | +$35.1K | +2 | +40% |
|
|
BCM
30
Bridgeway Capital Management
Houston,
Texas
| $95K | +$87.6K | +5 | New |
|
|
EEG
31
E.E. Geduld
| $93K | +$87.6K | +5 | New |
|
32
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $73K | +$70.1K | +4 | New |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| $45K | – | – | – |
|
34
UBS Group
Zurich,
Switzerland
| $16K | +$17.5K | +1 | New |
|
|
BIM
35
BlackRock Investment Management
Wilmington,
Delaware
| $14K | – | – | – |
|
|
LTFS
36
Ladenburg Thalmann Financial Services
Miami,
Florida
| $14K | – | – | – |
|
37
Wells Fargo
San Francisco,
California
| $14K | +$17.5K | +1 | New |
|
|
BIT
38
BlackRock Institutional Trust
San Francisco,
California
| $7K | – | – | – |
|
|
BG
39
BlackRock Group
London,
United Kingdom
| $6K | – | – | – |
|
|
TRCT
40
Tower Research Capital (TRC)
New York
| – | -$2K | – | – |
|
AGRX Hedge Fund Activity: Q1 2015 in Review
37 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Agile Therapeutics (AGRX) for Q1 2015, worth a combined $154M — up 92% from $80.1M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new AGRX positions and 0 closed out — a net gain of 18 holders — while 10 added to existing stakes and 3 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $12.8M. The largest seller was Sio Capital Management, cutting an estimated $4.78M.
- 37 institutional investors held Agile Therapeutics (AGRX) as of Q1 2015, up from 19 in Q4 2014.
- Funds reported $154M of Agile Therapeutics stock for Q1 2015, up 92% quarter-over-quarter.
- 18 funds opened new Agile Therapeutics positions in Q1 2015 and 0 closed out, a net change of +18 holders.
- The largest Agile Therapeutics buyer in Q1 2015 was RA Capital Management, an estimated $12.8M added.
- The largest Agile Therapeutics seller in Q1 2015 was Sio Capital Management, an estimated $4.78M sold.
Based on aggregated 13F filings for Q1 2015.